Healthequity (HQY) Enterprise Value (2013 - 2026)

Healthequity's Enterprise Value history runs 14 years deep, the most recent figure standing at -$265.4 million for Q2 2026.

• In Q2 2026, Enterprise Value rose 7.82% year-over-year to -$265.4 million; the TTM figure through Apr 2026 stood at -$265.4 million (up 7.82% YoY), while the FY2026 annual figure was -$318.9 million, down 7.76% from the prior year.
• Enterprise Value was -$265.4 million for Q2 2026 at Healthequity, up from -$318.9 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$161.2 million in Q2 2022 to a low of -$404.0 million in Q1 2024.
• Historically, Enterprise Value has averaged -$275.8 million across 5 years, with a median of -$289.1 million in 2023.
• The sharpest annual moves came in 2022 and 2023: Enterprise Value soared 78.11% in 2022, then plunged 64.14% in 2023.
• A 5-year view of Enterprise Value shows it stood at -$210.2 million in 2022, then plunged by 58.93% to -$334.1 million in 2023, then gained by 3.56% to -$322.2 million in 2024, then gained by 4.01% to -$309.3 million in 2025, then grew by 14.19% to -$265.4 million in 2026.
• The last three Enterprise Value figures came in at -$265.4 million (Q2 2026), -$318.9 million (Q1 2026), and -$309.3 million (Q4 2025), per Business Quant data.